Telomir Pharmaceuticals TELO Insider Ownership

Updated Oct 10, 2026

Over the past year, TELO insiders did not buy or sell the stock on the open market.

• Per Business Quant data, Telomir Pharmaceuticals insiders hold 10.59Mn shares in total based on their latest Form 4 filings, unchanged from 10.59Mn shares at the end of Q2 2026 and up 223.96% from 3.27Mn shares at the end of Q3 2025.
• Direct holdings account for 7.32Mn shares (69.13%) of TELO's insider total, and indirect holdings through trusts, partnerships and family members for 3.27Mn shares (30.87%).
• Per Business Quant, 2 insiders of TELO hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
• Telomir Pharmaceuticals' top two insider holders by shares held are Erez Aminov (CEO and Chairman, 7.32Mn shares) and Bay Shore Trust (10% owner, 3.27Mn shares).
• The holding of Erez Aminov makes up 69.13% of all shares held by Telomir Pharmaceuticals insiders.
• Institutional holders reported 4.33% of Telomir Pharmaceuticals' outstanding shares for Q2 2026; insiders' latest Form 4 filings put their stake at about 15.40%, and other investors, including the public, hold the remaining 80.27%.
• A total of 5 Form 4 filings with transactions in Telomir Pharmaceuticals stock were made over the past 12 months, by 4 insiders.
• This summary of Telomir Pharmaceuticals insider activity covers Form 4 filings through May 22, 2026.